Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-022837
Filing Date
2022-06-16
Accepted
2022-06-16 16:49:52
Documents
2
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4081
2 EX-24 DOCUMENT attachment1.htm EX-24 4420
  Complete submission text file 0000899243-22-022837.txt   9968
Mailing Address C/O 235 EAST 42ND ST. NEW YORK NY 10017
Business Address
Mckernan Ruth (Reporting) CIK: 0001531340 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 221021222

Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations